Quanterix Corporation (QTRX)

Market Cap	233.36M
Revenue (ttm)	135.69M
Net Income (ttm)	-47.87M
Shares Out	38.83M
EPS (ttm)	-1.24
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	283,647
Open	6.01
Previous Close	6.09
Day's Range	5.80 - 6.08
52-Week Range	4.05 - 15.86
Beta	1.12
Analysts	Buy
Price Target	13.50 (+124.63%)
Earnings Date	Aug 7, 2025

About QTRX

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Dec 7, 2017
• Employees: 471
• Stock Exchange: NASDAQ
• Ticker Symbol: QTRX
• Website: https://www.quanterix.com

Financial Performance

In 2024, Quanterix's revenue was $137.42 million, an increase of 12.30% compared to the previous year's $122.37 million. Losses were -$38.53 million, 35.9% more than in 2023.

Analyst Summary

According to 4 analysts, the average rating for QTRX stock is "Buy." The 12-month stock price target is $13.5, which is an increase of 124.63% from the latest price.

Price Target

$13.5

(124.63% upside)

Analyst Consensus: Buy